D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 85 Citations 30,118 355 World Ranking 223 National Ranking 111

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Antibiotics
  • Gene

His primary areas of study are Microbiology, Klebsiella pneumoniae, Antibiotics, Drug resistance and Antibacterial agent. His studies deal with areas such as Genetics, Gene, Enterobacteriaceae and Acinetobacter baumannii as well as Microbiology. His Acinetobacter baumannii research incorporates themes from Multiple drug resistance, Mutant, Acinetobacter, Autoinducer and Mobile genetic elements.

Robert A. Bonomo combines subjects such as Colistin, Carbapenem, Imipenem, Bacteremia and Internal medicine with his study of Klebsiella pneumoniae. His Antibiotics study integrates concerns from other disciplines, such as Biotechnology, Intensive care medicine, Combination therapy and Global health, Public health. His Antibacterial agent research is multidisciplinary, incorporating perspectives in Ceftazidime, Molecular epidemiology and Virology.

His most cited work include:

  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases (940 citations)
  • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases (940 citations)
  • Global Challenge of Multidrug-Resistant Acinetobacter baumannii (931 citations)

What are the main themes of his work throughout his whole career to date?

Robert A. Bonomo mainly focuses on Microbiology, Klebsiella pneumoniae, Antibiotics, Acinetobacter baumannii and Stereochemistry. The various areas that he examines in his Microbiology study include Ceftazidime and Enterobacteriaceae, Escherichia coli. His Klebsiella pneumoniae research focuses on Plasmid and how it relates to Virology.

His work deals with themes such as Antimicrobial, Intensive care medicine and Bacteria, which intersect with Antibiotics. His Acinetobacter baumannii research includes themes of Colistin, Drug resistance and Acinetobacter. His study looks at the relationship between Stereochemistry and fields such as Beta-Lactamase Inhibitors, as well as how they intersect with chemical problems.

He most often published in these fields:

  • Microbiology (69.14%)
  • Klebsiella pneumoniae (36.75%)
  • Antibiotics (30.01%)

What were the highlights of his more recent work (between 2017-2021)?

  • Microbiology (69.14%)
  • Antibiotics (30.01%)
  • Klebsiella pneumoniae (36.75%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Microbiology, Antibiotics, Klebsiella pneumoniae, Acinetobacter baumannii and Antibiotic resistance. His Microbiology research includes elements of Pseudomonas aeruginosa and Avibactam. His research integrates issues of Piperacillin/tazobactam and Escherichia coli in his study of Antibiotics.

He has researched Klebsiella pneumoniae in several fields, including Plasmid, Internal medicine, Aztreonam and Meropenem. His Acinetobacter baumannii study incorporates themes from Efflux, Transcriptome and Gene, Virulence. Robert A. Bonomo interconnects Antimicrobial, Enterobacteriaceae and Drug resistance in the investigation of issues within Antibiotic resistance.

Between 2017 and 2021, his most popular works were:

  • Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae (234 citations)
  • Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae (234 citations)
  • Carbapenemase-Producing Organisms: A Global Scourge (159 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Bacteria

Robert A. Bonomo mainly focuses on Microbiology, Acinetobacter baumannii, Antibiotics, Antibiotic resistance and Multiple drug resistance. His study in Microbiology is interdisciplinary in nature, drawing from both Pseudomonas aeruginosa, Klebsiella pneumoniae, Avibactam, Ceftazidime and Efflux. His studies in Klebsiella pneumoniae integrate themes in fields like Plasmid and Aztreonam.

His Acinetobacter baumannii study combines topics in areas such as Drug development, Drug, Drug resistance and Acinetobacter. His Antibiotics research integrates issues from Pharmacology and Public health. The study incorporates disciplines such as Rescue therapy, Enterobacteriaceae, Function and Enzyme in addition to Antibiotic resistance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global Challenge of Multidrug-Resistant Acinetobacter baumannii

Federico Perez;Andrea M. Hujer;Kristine M. Hujer;Brooke K. Decker.
Antimicrobial Agents and Chemotherapy (2007)

1503 Citations

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber.
Lancet Infectious Diseases (2013)

1188 Citations

Three Decades of β-Lactamase Inhibitors

Sarah M. Drawz;Robert A. Bonomo;Robert A. Bonomo.
Clinical Microbiology Reviews (2010)

1060 Citations

International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunlta Mohapatra.
Annals of Internal Medicine (2004)

772 Citations

Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory

David L. Paterson;David L. Paterson;Wen-Chien Ko;Anne Von Gottberg;Jose Maria Casellas.
Journal of Clinical Microbiology (2001)

756 Citations

Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

Robert A. Bonomo;Dora Szabo.
Clinical Infectious Diseases (2006)

747 Citations

Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases

David L. Paterson;David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunita Mohapatra.
Clinical Infectious Diseases (2004)

703 Citations

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

Helen W. Boucher;George H. Talbot;Daniel K. Benjamin;Daniel K. Benjamin;John Bradley;John Bradley.
Clinical Infectious Diseases (2013)

699 Citations

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Curtis J. Donskey;Tanvir K. Chowdhry;Michelle T. Hecker;Claudia K. Hoyen.
The New England Journal of Medicine (2000)

679 Citations

Carbapenems: Past, Present, and Future

Krisztina M. Papp-Wallace;Andrea Endimiani;Andrea Endimiani;Andrea Endimiani;Magdalena A. Taracila;Robert A. Bonomo.
Antimicrobial Agents and Chemotherapy (2011)

559 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert A. Bonomo

Patrice Nordmann

Patrice Nordmann

University of Fribourg

Publications: 131

David L. Paterson

David L. Paterson

University of Queensland

Publications: 126

Gian Maria Rossolini

Gian Maria Rossolini

University of Florence

Publications: 125

Yohei Doi

Yohei Doi

University of Pittsburgh

Publications: 112

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 98

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 81

David M. Livermore

David M. Livermore

University of East Anglia

Publications: 80

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 79

Jesús Rodríguez-Baño

Jesús Rodríguez-Baño

University of Seville

Publications: 76

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 76

Yehuda Carmeli

Yehuda Carmeli

Israel Ministry of Health

Publications: 71

Barry N. Kreiswirth

Barry N. Kreiswirth

Center for Discovery and Innovation

Publications: 70

Anton Y. Peleg

Anton Y. Peleg

Monash University

Publications: 68

Thierry Naas

Thierry Naas

University of Paris-Saclay

Publications: 67

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 67

Liang Chen

Liang Chen

Rutgers, The State University of New Jersey

Publications: 65

Something went wrong. Please try again later.